Showing results (31-40 of 38) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 25, 2017
Pharmacokinetics of a novel extended half-life glycoPEGylated factor IX, nonacog beta pegol (N9-GP) in previously treated patients with haemophilia B: results from two phase 3 clinical trialsA Tiede, F Abdul-Karim, M Carcao, et al.Clinical and Experimental Rheumatology|July 17, 2007
The Gap Study (GapS) interview--developing a process to determine the meaning and determinants of quality of life in children with arthritis and rheumatic diseaseG W K Gong, M Barrera, J Beyene, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|November 17, 2007
Recommendations for reporting economic evaluations of haemophilia prophylaxis: a nominal groups consensus statement on behalf of the Economics Expert Working Group of The International Prophylaxis Study GroupA Nicholson, K Berger, R Bohn, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|April 26, 2017
Comparing the burden of illness of haemophilia between resource-constrained and unconstrained countries: the São Paulo-Toronto Hemophilia StudyJ D A Carneiro, V Blanchette, M C Ozelo, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|February 14, 2018
Recombinant factor VIII Fc fusion protein for immune tolerance induction in patients with severe haemophilia A with inhibitors-A retrospective analysisM Carcao, A Shapiro, J M Staber, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|September 17, 2016
Choosing outcome assessment tools in haemophilia care and research: a multidisciplinary perspectiveK Fischer, P Poonnoose, A L Dunn, et al.Journal of Medical Genetics|June 11, 2011
Genetic analysis of inherited bone marrow failure syndromes from one prospective, comprehensive and population-based cohort and identification of novel mutationsE Tsangaris, R Klaassen, C V Fernandez, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|August 18, 2017
Immunogenicity, efficacy and safety of Nuwiq® (human-cl rhFVIII) in previously untreated patients with severe haemophilia A-Interim results from the NuProtect StudyR J Liesner, M Abashidze, O Aleinikova, et al.Pageof 4